BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32894306)

  • 1. Organisation of the human pancreas in health and in diabetes.
    Atkinson MA; Campbell-Thompson M; Kusmartseva I; Kaestner KH
    Diabetologia; 2020 Oct; 63(10):1966-1973. PubMed ID: 32894306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
    Tomita T
    Islets; 2011; 3(4):166-74. PubMed ID: 21633185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.
    Levetan CS; Pierce SM
    Endocr Pract; 2013; 19(2):301-12. PubMed ID: 23186955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas.
    Atkinson MA; Mirmira RG
    Cell Metab; 2023 Sep; 35(9):1500-1518. PubMed ID: 37478842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signals in the pancreatic islet microenvironment influence β-cell proliferation.
    Aamodt KI; Powers AC
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1(Suppl 1):124-136. PubMed ID: 28880471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes.
    Amo-Shiinoki K; Tanabe K; Hoshii Y; Matsui H; Harano R; Fukuda T; Takeuchi T; Bouchi R; Takagi T; Hatanaka M; Takeda K; Okuya S; Nishimura W; Kudo A; Tanaka S; Tanabe M; Akashi T; Yamada T; Ogawa Y; Ikeda E; Nagano H; Tanizawa Y
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.
    Ueberberg S; Jütte H; Uhl W; Schmidt W; Nauck M; Montanya E; Tannapfel A; Meier J
    Diabetes Obes Metab; 2016 Dec; 18(12):1253-1262. PubMed ID: 27545110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of the pancreatic endocrine cells of the nude mouse, Balb/c-nu/nu.
    Ku SK; Lee HS
    Eur J Histochem; 2006; 50(1):61-8. PubMed ID: 16584986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas).
    Guardado Mendoza R; Perego C; Finzi G; La Rosa S; Capella C; Jimenez-Ceja LM; Velloso LA; Saad MJ; Sessa F; Bertuzzi F; Moretti S; Dick EJ; Davalli AM; Folli F
    Diabetologia; 2015 Aug; 58(8):1814-26. PubMed ID: 26049399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.
    Bruggeman BS; Campbell-Thompson M; Filipp SL; Gurka MJ; Atkinson MA; Schatz DA; Jacobsen LM
    Front Endocrinol (Lausanne); 2021; 12():778912. PubMed ID: 34912300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
    Iki K; Pour PM
    J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased pancreatic acinar cell number in type 1 diabetes.
    Wright JJ; Saunders DC; Dai C; Poffenberger G; Cairns B; Serreze DV; Harlan DM; Bottino R; Brissova M; Powers AC
    Diabetologia; 2020 Jul; 63(7):1418-1423. PubMed ID: 32388592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository.
    Bonnet-Serrano F; Diedisheim M; Mallone R; Larger E
    PLoS One; 2018; 13(1):e0191528. PubMed ID: 29352311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic volume and endocrine and exocrine functions in patients with diabetes.
    Philippe MF; Benabadji S; Barbot-Trystram L; Vadrot D; Boitard C; Larger E
    Pancreas; 2011 Apr; 40(3):359-63. PubMed ID: 21283038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas.
    Saisho Y
    Rev Diabet Stud; 2016; 13(2-3):132-147. PubMed ID: 28012279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology of Type 1 Diabetes Pancreas.
    Willcox A; Gillespie KM
    Methods Mol Biol; 2016; 1433():105-17. PubMed ID: 26801316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.